Prevention of hepatocyte allograft rejection in rats by transferring adenoviral early region 3 genes into donor cells

Hepatology

Volumn 45, Issue 3, 2007, Pages 755-766

  Mashalova, Elena V ^a   Guha, Chandan ^a   Roy Chowdhury, Namita ^a   Liu, Laibin ^a   Fox, Ira J ^b   Roy Chowdhury, Jayanta ^a   Horwitz, Marshall S ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ADE3 GENE; ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DNA MODIFICATION; GENE; GENE TRANSFER; GENETIC TRANSFECTION; GRAFT SURVIVAL; HEPATOCYTE TRANSPLANTATION; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS GENE; VIRUS GENOME; WESTERN BLOTTING;

ADENOVIRUS E3 PROTEINS; ANIMALS; ANTIGENS, CD95; APOPTOSIS; CELL LINE; CELL TRANSPLANTATION; GENE EXPRESSION REGULATION, VIRAL; GENES, MHC CLASS I; GENES, VIRAL; GRAFT REJECTION; HEPATOCYTES; RATS; RATS, GUNN; RATS, INBRED F344; RATS, INBRED LEW; RATS, WISTAR; TRANSFECTION; TRANSPLANTATION, HOMOLOGOUS;

EID: 33947395299     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21525     Document Type: Article

References (44)

1. Horslen SP, Fox IJ. Hepatocyte transplantation. Transplantation 2004;77: 1481-1486.
2. Bumgardner GL, Orosz CG. Unusual patterns of alloimmunity evoked by allogeneic liver parenchymal cells. Immunol Rev 2000;174:260-279.
3. Bumgardner GL, Gao D, Li J, Baskin JH, Heininger M, Orosz CG. Rejection responses to allogeneic hepatocytes by reconstituted SCID mice, CD4, KO, and CD8 KO mice. Transplantation 2000;70:1771-1780.
4. Bumgardner GL, Gao D, Li J, Bickerstaff A, Orosz CG. MHC-identical heart and hepatocyte allografts evoke opposite immune responses within the same host. Transplantation 2002;74:855-864.
5. Lunsford KE, Gao D, Eiring AM, Wang Y, Frankel WL, Bumgardner GL. Evidence for tissue-directed immune responses: analysis of CD4- and CD8-dependent alloimmunity. Transplantation 2004;78:1125-1133.
6. Gomez-Lechon MJ, Serralta A, Donato MT, Jimenez N, O'Connor E, Castell JV, et al. The immunosuppressant drug FK506 prevents Fas-induced apoptosis in human hepatocytes. Biochem Pharmacol 2004;68: 2427-2433.
7. Rivero M, Crespo J, Mayorga M, Fabrega E, Casafont F, Pons-Romero F. Involvement of the Fas system in liver allograft rejection. Am J Gastroenterol 2002;97:1501-1506.
8. Kawahara T, Yagita H, Kasai S, Sawa M, Kato K, Okumura K, et al. Allogeneic hepatocyte transplantation: contribution of Fas-Fas ligand interaction to allogeneic hepatocyte rejection. J Gastroenterol Hepatol 1998; 13(Suppl):S119-S123.
9. Wang J, Li W, Min J, Ou Q, Chen J. Fas siRNA reduces apoptotic cell death of allogeneic-transplanted hepatocytes in mouse spleen. Transplant Proc 2003;35:1594-1595.
10. Yin XM, Ding WX. Death receptor activation-induced hepatocyte apoptosis and liver injury. Curr Mol Med 2003;3:491-508.
11. Horwitz MS. Function of adenovirus E3 proteins and their interactions with immunoregulatory cell proteins. J Gene Med 2004;6(Suppl 1):S172-S183.
12. Cox JH, Bennink JR, Yewdell JW. Retention of adenovirus E19 glycoprotein in the endoplasmic reticulum is essential to its ability to block antigen presentation. J Exp Med 1991;174:1629-1637.
13. Liu H, Stafford WF, Bouvier M. The endoplasmic reticulum lumenal domain of the adenovirus type 2 E3-19K protein binds to peptide-filled and peptide-deficient HLA-A*1101 molecules. J Virol 2005;79:13317-13325.
14. Bennett EM, Bennink JR, Yewdell JW, Brodsky FM. Cutting edge: adenovirus E19 has two mechanisms for affecting class I MHC expression. J Immunol 1999;162:5049-5052.
15. Elsing A, Burgert HG. The adenovirus E3/10.4K-14.5K proteins down-modulate the apoptosis receptor Fas/Apo-1 by inducing its internalization. Proc Natl Acad Sci U S A 1998;95:10072-10077.
16. Shisler J, Yang C, Walter B, Ware CF, Gooding LR. The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis. J Virol 1997;71:8299-8306.
17. Tollefson AE, Hermiston TW, Lichtenstein DL, Colle CF, Tripp RA, Dimitrov T, et al. Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells. Nature 1998;392:726-730.
18. Benedict CA, Norris PS, Prigozy TI, Bodmer JL, Mahr JA, Garnett CT, et al. Three adenovirus E3 proteins cooperate to evade apoptosis by tumor necrosis factor-related apoptosis-inducing ligand receptor-1 and -2. J Biol Chem 2001;276:3270-3278.
19. Tollefson AE, Toth K, Doronin K, Kuppuswamy M, Doronina OA, Lichtenstein DL, et al. Inhibition of TRAIL-induced apoptosis and forced internalization of TRAIL receptor 1 by adenovirus proteins. J Virol 2001; 75:8875-8887.
20. Fessler SP, Chin YR, Horwitz MS. Inhibition of tumor necrosis factor (TNF) signal transduction by the adenovirus group C RID complex involves downregulation of surface levels of TNF receptor 1. J Virol 2004; 78:13113-13121.
21. Chin YR, Horwitz MS. Mechanism for removal of tumor necrosis factor receptor 1 from the cell surface by the adenovirus RIDalpha/beta complex. J Virol 2005;79:13606-13617.
22. Dimitrov T, Krajcsi P, Hermiston TW, Tollefson AE, Hannink M, Wold WS. Adenovirus E3-10.4K/14.5K protein complex inhibits tumor necrosis factor-induced translocation of cytosolic phospholipase A2 to membranes. J Virol 1997;71:2830-2837.
23. Krajcsi P, Dimitrov T, Hermiston TW, Tollefson AE, Ranheim TS, Vande Pol SB, et al. The adenovirus E3-14.7K protein and the E3-10.4K/ 14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid. J Virol 1996;70:4904-4913.
24. Chen P, Tian J, Kovesdi I, Bruder JT. Interaction of the adenovirus 14.7-kDa protein with FLICE inhibits Fas ligand-induced apoptosis. J Biol Chem 1998;273:5815-5820.
25. Carmody RJ, Maguschak K, Chen YH. A novel mechanism of nuclear factor-kappaB regulation by adenoviral protein 14.7K. Immunology 2006; 117(2):188-195.
26. Efrat S, Fejer G, Brownlee M, Horwitz MS. Prolonged survival of pancreatic islet allografts mediated by adenovirus immunoregulatory transgenes. Proc Natl Acad Sci U S A 1995;92:6947-6951.
27. von Herrath MG, Efrat S, Oldstone MB, Horwitz MS. Expression of adenoviral E3 transgenes in beta cells prevents autoimmune diabetes. Proc Natl Acad Sci U S A 1997;94:9808-9813.
28. Efrat S, Serteze D, Svetlanov A, Post CM, Johnson EA, Herold K, et al. Adenovirus early region 3(E3) immunomodulatory genes decrease the incidence of autoimmune diabetes in NOD mice. Diabetes 2001;50:980-984.
29. Fox IJ, Chowdhury NR, Gupta S, Kondapalli R, Schilsky ML, Stockert RJ, et al. Conditional immortalization of Gunn rat hepatocytes: an ex vivo model for evaluating methods for bilirubin-UDP-glucuronosyltransferase gene transfer. HEPATOLOGY 1995;21:837-846.
30. Cai J, Ito M, Nagata H, Westerman KA, Lafleur D, Chowdhury JR, et al. Treatment of liver failure in rats with end-stage cirrhosis by transplantation of immortalized hepatocytes. HEPATOLOGY 2002;36:386-394.
31. Westerman KA, Leboulch P. Reversible immortalization of mammalian cells mediated by retroviral transfer and site-specific recombination. Proc Natl Acad Sci U S A 1996;93:8971-8976.
32. Ilan Y, Droguett G, Chowdhury NR, Li Y, Sengupta K, Thummala NR, et al. Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression. Proc Natl Acad Sci U S A 1997;94:2587-2592.
33. Guha C, Parashar B, Deb NJ, Garg M, Gorla GR, Singh A, et al. Normal hepatocytes correct serum bilirubin after repopulation of Gunn rat liver subjected to irradiation/partial resection. HEPATOLOGY 2002;36:354-362.
34. Toth K, Doronin K, Kuppuswamy M, Ward P, Tollefson AE, Wold WS. Adenovirus immunoregulatory E3 proteins prolong transplants of human cells in immunocompetent mice. Virus Res 2005;108(1-2):149-159.
35. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998;72:8463-8471.
36. Fejer G, Gyory I, Tufariello J, Horwitz MS. Characterization of transgenic mice containing adenovirus early region 3 genomic DNA. J Virol 1994; 68:5871-5881.
37. Heinsohn S, Golta S, Kabisch H, zur SU. Standardized detection of Simian virus 40 by real-time quantitative polymerase chain reaction in pediatric malignancies. Haematologica 2005;90(1):94-99.
38. Gupta S, Chowdhury NR, Jagtiani R, Gustin K, Aragona E, Shafritz DA, et al. A novel system for transplantation of isolated hepatocytes utilizing HBsAg-producing transgenic donor cells. Transplantation 1990;50:472-475.
39. Ponder KP, Gupta S, Leland F, Darlington G, Finegold M, DeMayo J, et al. Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc Natl Acad Sci U S A 1991; 88:1217-1221.
40. Kaulek V, Saas P, Alexandre E, Grant H, Richert L, Jaeck D, et al. Comparative phenotype and immunogenicity of freshly isolated and immortalized rat hepatocytes. Cell Transplant 2001;10:739-747.
41. Beier DC, Cox JH, Vining DR, Cresswell P, Engelhard VH. Association of human class I MHC alleles with the adenovirus E3/19K protein. J Immunol 1994;152:3862-3872.
42. Pierce MA, Chapman HD, Post CM, Svetlanov A, Efrat S, Horwitz M, et al. Adenovirus early region 3 antiapoptotic 10.4K, 14.5K, and 14.7K genes decrease the incidence of autoimmune diabetes in NOD mice. Diabetes 2003;52:1119-1127.
43. Nagakawa Y, Williams GM, Zheng Q, Tsuchida A, Aoki T, Montgomery RA, et al. Oxidative mitochondrial DNA damage and deletion in hepatocytes of rejecting liver allografts in rats: role of TNF-alpha. HEPATOLOGY 2005;42(1):208-215.
44. Chen G, Goeddel DV. TNF-R1 signaling: a beautiful pathway. Science 2002;296:1634-1635.